You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study
|
---|---|
Published in |
Diabetologia, January 2012
|
DOI | 10.1007/s00125-011-2447-3 |
Pubmed ID | |
Authors |
B. Eliasson, D. Möller-Goede, K. Eeg-Olofsson, C. Wilson, J. Cederholm, P. Fleck, M. Diamant, M.-R. Taskinen, U. Smith |
Abstract |
Pharmacological augmentation of glucagon-like peptide 1 receptor signalling by dipeptidyl peptidase 4 (DPP-4) inhibition reduced intestinal lipoprotein secretion in experimental studies, suggesting that DPP-4 inhibitors may ameliorate dyslipidaemia and thus reduce cardiovascular risk in patients with type 2 diabetes. We assessed the effects of alogliptin (Alo) and Alo co-administered with pioglitazone (Pio) vs placebo (Pbo) on triacylglycerol (TG)-rich lipoproteins in type 2 diabetes before and following a high-fat meal. |
Mendeley readers
The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 2 | 2% |
United Kingdom | 1 | <1% |
Brazil | 1 | <1% |
Mexico | 1 | <1% |
Denmark | 1 | <1% |
Spain | 1 | <1% |
Japan | 1 | <1% |
United States | 1 | <1% |
Unknown | 104 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 21 | 19% |
Student > Master | 20 | 18% |
Other | 11 | 10% |
Student > Ph. D. Student | 10 | 9% |
Professor | 8 | 7% |
Other | 27 | 24% |
Unknown | 16 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 55 | 49% |
Pharmacology, Toxicology and Pharmaceutical Science | 10 | 9% |
Agricultural and Biological Sciences | 10 | 9% |
Nursing and Health Professions | 9 | 8% |
Biochemistry, Genetics and Molecular Biology | 3 | 3% |
Other | 8 | 7% |
Unknown | 18 | 16% |